A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

March 22, 2019

Primary Completion Date

July 3, 2019

Study Completion Date

July 10, 2019

Conditions

Dry Eye

Interventions

DRUG

HBM9036 0.25% Ophthalmic Solution

Ophthalmic Solution

DRUG

placebo

Ophthalmic Solution

Trial Locations (1)

Qingdao Eye Hospital, Qingdao

All Listed Sponsors

lead

Harbour BioMed (Guangzhou) Co. Ltd.

INDUSTRY

NCT04092907 - A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye | Biotech Hunter | Biotech Hunter